Assignment of HLA-antigens in CREGs facilitates the detection of acceptable mismatches in highly sensitized patients

Human Immunology

Volumn 59, Issue 9, 1998, Pages 587-596

  Papassavas, Andreas C ^a   Iniotaki Theodoraki, Aliki ^a   Boletis, John ^b   Kostakis, Alkiviadis ^b   Stavropoulos Giokas, Catherine ^a  

^a KAT HOSPITAL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA B ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTOTOXICITY; MALE; PHENOTYPE; PRIORITY JOURNAL; SENSITIZATION; T LYMPHOCYTE;

ADULT; CROSS REACTIONS; EPITOPES; FEMALE; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; MALE; MIDDLE AGED; TRANSPLANTATION IMMUNOLOGY;

EID: 0031683999     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00051-2     Document Type: Article

References (29)

1. Rodey G.E., Fuller T.C. Public epitopes and the antigenic structure of HLA molecules. CRC Ctic Rev Immunol. 7:1987;229.
2. Fuller T.C. Monitoring HLA alloimmunization Analysis of HLA alloantibodies in the serum of prospective transplant recipients . Clin Lab Med. 11:1991;551.
3. Rodey G.E., Anderson J., Kunicki J., Aster R.H. Procurement and identification of HLA lymphocytotoxic antibodies in sera of non-pregnant multiparous blood donors. Transfusion. 14:1974;167.
4. Scornik J.C., Ireland J.E., Howard R.J., Plaff W.W. Assessment of the risk for broad sensitization by blood transfusions. Transplantation. 37:1984;249.
5. Sanfilippo F., Goeken N., Niblack G., Scornik J., Vaughn W.K. Comperative effects on pregnancy, transfusion, and prior graft rejection on sensitization and renal transplant results. Transplantation. 34:1982;360.
6. Rodey G.E., Neylan J.F., Whelchel J.D., Revels K.W., Bray R.A. Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant pecipients. Hum Immunol. 39:1994;272.
7. Oldfather J.W., Anderson C.B., Phelan D.L., Cross D.E., Luger A.M., Rodey G.E. Prediction of crossmatch outcome in highly sensitized patients based on the identification of serum HLA antibodies. Transplantation. 42:1986;267.
8. Rodey G.E., Revels K., Fuller T.C. Epitope specificity of HLA class I alloantibodies. II. Stability of cross-reactive group antibody over extended time periods. Transplantation. 63:1997;885.
9. Delmonico F.L., Fuller A., Cosimi A.B., Tolkoff-Rubin N., Russell P.S., Rodey G.E., Fuller T.C. New approaches to donor crossmatching and successful transplantation of highly sensitized patients. Transplantation. 36:1983;629.
10. Rodey GE: HLA class I CREG antibodies: Detection and clinical significance. 23rd Annual Meeting, American Society for Histocompatibility and Immunogenetics, Atlanta, October 14-19, 1997.
11. Nisperos B. Density gradient isolation of peripheral blood lymphocytes: Augmentation with monoclonal antibodies. In Zachary AA, Terisi GA (eds): (2nd ed): ASHI Laboratory Manual, p. 28-31, 1990.
12. Johnson A.H., Rossen R.D., Butler W.T. Detection of alloantibodies using a sensitive antiglobulin microcytotoxicity test Identification of low levels of pre-formed antibodies in accelerated allograft rejection . Tissue Antigens. 2:1972;215.
13. Zachary A.A., Griffin J., Lucas D.P., Hart J.M., Leffell M.S. Evaluation of HLA antibodies with PRA-STAT. Transplantation. 60:1995;1600.
14. Bradley B.A., Gore S.M. Council of Europe study of highly sensitization in renal transplantation. Transpl Proc. 19:1987;3742.
15. Opelz G. Kidney transplantation in sensitized patients. Transpl Proc. 19:1987;3737.
16. Fauchald P., Leivestad T., Bratlie A., Alberchsten D., Talseth, Flat-Mart A. Plasma exchange and immunosuppressive therapy before renal transplantation. Transpl Proc. 19:1987;3748.
17. Palmer A., Taube D., Welsh K.I., Bewick M., Gjorstrup P., Thick M. Removal of anti-HLA antibodies by extracorporeal immunoabsorption to enable renal transplantation. Lancet. 1:1989;10.
18. Thompson J.S., Bryne J.E., Hempel H.O., Oldfather J.W., Green W.F., Crowe D.O., Sanfilippo F., MacQueen J.M., McCalmon R.N., Tardiff G.N., Helman S.W. Computer algorithm that predicts both acceptable and unacceptable private and public HLA class I antigens in highly sensitized patients. Transpl Proc. 25:1993;251.
19. Claas F.H.J., Gijbels Y., De Waal L.P., D'Amaro J., Perjijn G.G., Van Rood J.J. Selection of crossmatch negative HLA-A and/or -B mismatched donors for highly sensitized patients. Transpl Proc. 21:1989;665.
20. Claas F.H.J., Van Leeuwen A., Van Rood J.J. Hyperimmunized patients do not need to wait for an HLA identical donor. Tissue Antigens. 34:1989;23.
21. Laundy G.J., Bradley B.A. Epitope analysis A strategy for intelligent mismatching in highly sensitized patients . Transpl Immunol. 2:1994;140.
22. Laundy G.J., Bradley B.A. The predictive value of epitope analysis in highly sensitized patients awaiting renal transplantation. Transplantation. 59:1995;1207.
23. Duquesnoy R.J., White L.T., Iwaki Y., Vanek M. Multiscreen analysis of high PRA sera for antibodies towards public and private class I antigens Implications for computer-predicted acceptable donors for kidney transplant candidates . Transpl Proc. 23:1991;387.
24. Duquesnoy R.J., White L.T., Fierst J.W., Vanek M., Banner B.F., Iwaki Y., Starzl T.E. Multiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private class HLA determinants Implications for computer-predicted acceptable and unacceptable donor mismatches in kidney transplantation . Transplantation. 50:1990;427.
25. Harmer A.W., Heads A.J., Vaughan R.W. Detection of HLA class-I and class-II specific antibodies by flow cytometry and PRA-STAT screening in renal transplant recipients. Transplantation. 63:1997;1828.
26. Papassavas A.C., Iniotaki-Theodoraki A., Stathakopoulou A., Ioannou S., Kostakis A., Stavropoulos-Giokas C. Evaluation of HLA-class I directed alloantibodies using PRA-STAT and CDC techniques. Transpl Proc. 30:1998;724.
27. Rodey G.E., Parker M., Neylan J., Lowance D., O'Brien D., Wlelchel J. Antibodies to public class I epitopes in the American black populations. Transpl Proc. 21:1989;3878.
28. Figueroa F., Gunther E., Klein J. MHC polymorphism pre-dating speciation. Nature. 335:1988;265.
29. Lawlor D.A., Ward F.E., Ennis P.D., Jackson A.P., Parham P. HLA-A and polymorphisms predate the divergence of humans and chimpanzees. Nature. 335:1988;268.